for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Atyr Pharma Announces Dosing Of First Patient In Phase 2 Trial Of ATYR1923 In Covid-19 Patients

June 15 (Reuters) - aTyr Pharma Inc:

* ATYR PHARMA ANNOUNCES DOSING OF FIRST PATIENT IN PHASE 2 TRIAL OF ATYR1923 IN COVID-19 PATIENTS WITH SEVERE RESPIRATORY COMPLICATIONS

* ATYR PHARMA ANNOUNCES DOSING OF FIRST PATIENT IN PHASE 2 TRIAL OF ATYR1923 IN COVID-19 PATIENTS WITH SEVERE RESPIRATORY COMPLICATIONS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up